These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 33836690
1. The CErebro Placental RAtio as indicator for delivery following perception of reduced fetal movements, protocol for an international cluster randomised clinical trial; the CEPRA study. Damhuis SE, Ganzevoort W, Duijnhoven RG, Groen H, Kumar S, Heazell AEP, Khalil A, Gordijn SJ. BMC Pregnancy Childbirth; 2021 Apr 09; 21(1):285. PubMed ID: 33836690 [Abstract] [Full Text] [Related]
2. Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Akolekar R, Ciobanu A, Zingler E, Syngelaki A, Nicolaides KH. Am J Obstet Gynecol; 2019 Jul 09; 221(1):65.e1-65.e18. PubMed ID: 30878322 [Abstract] [Full Text] [Related]
3. Is the fetal cerebroplacental ratio better that the estimated fetal weight in predicting adverse perinatal outcomes in a low risk cohort? Flatley C, Kumar S. J Matern Fetal Neonatal Med; 2019 Jul 09; 32(14):2380-2386. PubMed ID: 29455616 [Abstract] [Full Text] [Related]
4. Cerebroplacental ratio assessment in early labor in uncomplicated term pregnancy and prediction of adverse perinatal outcome: prospective multicenter study. Dall'Asta A, Ghi T, Rizzo G, Cancemi A, Aloisio F, Arduini D, Pedrazzi G, Figueras F, Frusca T. Ultrasound Obstet Gynecol; 2019 Apr 09; 53(4):481-487. PubMed ID: 29900608 [Abstract] [Full Text] [Related]
5. A low fetal cerebroplacental ratio confers a greater risk of intrapartum fetal compromise and adverse neonatal outcomes in low risk multiparous women at term. Turner JM, Flatley C, Kumar S. Eur J Obstet Gynecol Reprod Biol; 2018 Nov 09; 230():15-21. PubMed ID: 30237135 [Abstract] [Full Text] [Related]
6. Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36+ 0 weeks gestation. Armstrong-Buisseret L, Mitchell E, Hepburn T, Duley L, Thornton JG, Roberts TE, Storey C, Smyth R, Heazell AEP. Trials; 2018 Oct 01; 19(1):531. PubMed ID: 30285835 [Abstract] [Full Text] [Related]
7. Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss. Khalil A, Morales-Roselló J, Townsend R, Morlando M, Papageorghiou A, Bhide A, Thilaganathan B. Ultrasound Obstet Gynecol; 2016 Jan 01; 47(1):74-80. PubMed ID: 26327300 [Abstract] [Full Text] [Related]
8. Prediction of adverse perinatal outcome by cerebroplacental ratio adjusted for estimated fetal weight. Sirico A, Diemert A, Glosemeyer P, Hecher K. Ultrasound Obstet Gynecol; 2018 Mar 01; 51(3):381-386. PubMed ID: 28294442 [Abstract] [Full Text] [Related]
9. Magnitude of change in fetal cerebroplacental ratio in third trimester and risk of adverse pregnancy outcome. Flatley C, Greer RM, Kumar S. Ultrasound Obstet Gynecol; 2017 Oct 01; 50(4):514-519. PubMed ID: 27873370 [Abstract] [Full Text] [Related]
10. Prediction of adverse perinatal outcome by cerebroplacental ratio in women undergoing induction of labor. Fiolna M, Kostiv V, Anthoulakis C, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2019 Apr 01; 53(4):473-480. PubMed ID: 30426578 [Abstract] [Full Text] [Related]
11. Reduced fetal movements and cerebroplacental ratio: evidence for worsening fetal hypoxemia. Binder J, Monaghan C, Thilaganathan B, Morales-Roselló J, Khalil A. Ultrasound Obstet Gynecol; 2018 Mar 01; 51(3):375-380. PubMed ID: 28782146 [Abstract] [Full Text] [Related]
12. Cerebroplacental ratio (CPR) and reduced fetal movement: predicting neonatal outcomes. Eshraghi N, Jamal A, Eshraghi N, Kashanian M, Sheikhansari N. J Matern Fetal Neonatal Med; 2022 May 01; 35(10):1923-1928. PubMed ID: 32495705 [Abstract] [Full Text] [Related]
13. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2016 Feb 01; 47(2):194-202. PubMed ID: 26094952 [Abstract] [Full Text] [Related]
14. Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study. MacDonald TM, Hui L, Robinson AJ, Dane KM, Middleton AL, Tong S, Walker SP. Ultrasound Obstet Gynecol; 2019 Sep 01; 54(3):367-375. PubMed ID: 30338593 [Abstract] [Full Text] [Related]
15. Reduced growth velocity from the mid-trimester is associated with placental insufficiency in fetuses born at a normal birthweight. Kennedy LM, Tong S, Robinson AJ, Hiscock RJ, Hui L, Dane KM, Middleton AL, Walker SP, MacDonald TM. BMC Med; 2020 Dec 24; 18(1):395. PubMed ID: 33357243 [Abstract] [Full Text] [Related]
16. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2016 Feb 24; 47(2):203-9. PubMed ID: 26224608 [Abstract] [Full Text] [Related]
17. Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome. Bakalis S, Akolekar R, Gallo DM, Poon LC, Nicolaides KH. Ultrasound Obstet Gynecol; 2015 Apr 24; 45(4):409-20. PubMed ID: 25684172 [Abstract] [Full Text] [Related]
18. The importance of the cerebroplacental ratio in the evaluation of fetal well-being in SGA and AGA fetuses. DeVore GR. Am J Obstet Gynecol; 2015 Jul 24; 213(1):5-15. PubMed ID: 26113227 [Abstract] [Full Text] [Related]
19. Are fetuses that fail to achieve their growth potential at increased risk of intrapartum compromise? Prior T, Paramasivam G, Bennett P, Kumar S. Ultrasound Obstet Gynecol; 2015 Oct 24; 46(4):460-4. PubMed ID: 25487285 [Abstract] [Full Text] [Related]
20. An abnormal cerebroplacental ratio (CPR) is predictive of early childhood delayed neurodevelopment in the setting of fetal growth restriction. Monteith C, Flood K, Pinnamaneni R, Levine TA, Alderdice FA, Unterscheider J, McAuliffe FM, Dicker P, Tully EC, Malone FD, Foran A. Am J Obstet Gynecol; 2019 Sep 24; 221(3):273.e1-273.e9. PubMed ID: 31226291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]